Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

179 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Brain injury in the international multicenter randomized SafeBoosC phase II feasibility trial: cranial ultrasound and magnetic resonance imaging assessments.
Plomgaard AM, Hagmann C, Alderliesten T, Austin T, van Bel F, Claris O, Dempsey E, Franz A, Fumagalli M, Gluud C, Greisen G, Hyttel-Sorensen S, Lemmers P, Pellicer A, Pichler G, Benders M. Plomgaard AM, et al. Among authors: hagmann c. Pediatr Res. 2016 Mar;79(3):466-72. doi: 10.1038/pr.2015.239. Epub 2015 Nov 16. Pediatr Res. 2016. PMID: 26571218 Free PMC article. Clinical Trial.
Clinical use of cerebral oximetry in extremely preterm infants is feasible.
Hyttel-Sørensen S, Austin T, van Bel F, Benders M, Claris O, Dempsey EM, Fumagalli M, Gluud C, Hagmann C, Hellström-Westas L, Lemmers P, Naulaers G, van Oeveren W, Pellicer A, Pichler G, Roll C, Støy LS, Wolf M, Greisen G. Hyttel-Sørensen S, et al. Among authors: hagmann c. Dan Med J. 2013 Jan;60(1):A4533. Dan Med J. 2013. PMID: 23340184 Free article. Clinical Trial.
A phase II randomized clinical trial on cerebral near-infrared spectroscopy plus a treatment guideline versus treatment as usual for extremely preterm infants during the first three days of life (SafeBoosC): study protocol for a randomized controlled trial.
Hyttel-Sorensen S, Austin T, van Bel F, Benders M, Claris O, Dempsey E, Fumagalli M, Greisen G, Grevstad B, Hagmann C, Hellström-Westas L, Lemmers P, Lindschou J, Naulaers G, van Oeveren W, Pellicer A, Pichler G, Roll C, Skoog M, Winkel P, Wolf M, Gluud C. Hyttel-Sorensen S, et al. Among authors: hagmann c. Trials. 2013 May 1;14:120. doi: 10.1186/1745-6215-14-120. Trials. 2013. PMID: 23782447 Free PMC article. Clinical Trial.
The SafeBoosC phase II randomised clinical trial: a treatment guideline for targeted near-infrared-derived cerebral tissue oxygenation versus standard treatment in extremely preterm infants.
Pellicer A, Greisen G, Benders M, Claris O, Dempsey E, Fumagalli M, Gluud C, Hagmann C, Hellström-Westas L, Hyttel-Sorensen S, Lemmers P, Naulaers G, Pichler G, Roll C, van Bel F, van Oeveren W, Skoog M, Wolf M, Austin T. Pellicer A, et al. Among authors: hagmann c. Neonatology. 2013;104(3):171-8. doi: 10.1159/000351346. Epub 2013 Aug 1. Neonatology. 2013. PMID: 23921600 Free article. Clinical Trial.
Cerebral near infrared spectroscopy oximetry in extremely preterm infants: phase II randomised clinical trial.
Hyttel-Sorensen S, Pellicer A, Alderliesten T, Austin T, van Bel F, Benders M, Claris O, Dempsey E, Franz AR, Fumagalli M, Gluud C, Grevstad B, Hagmann C, Lemmers P, van Oeveren W, Pichler G, Plomgaard AM, Riera J, Sanchez L, Winkel P, Wolf M, Greisen G. Hyttel-Sorensen S, et al. Among authors: hagmann c. BMJ. 2015 Jan 5;350:g7635. doi: 10.1136/bmj.g7635. BMJ. 2015. PMID: 25569128 Free PMC article. Clinical Trial.
179 results